Holen Sie sich die Stockscreener-App
18.98
2.22%
-0.43
Handel nachbörslich:
18.98
Schlusskurs vom Vortag:
$19.41
Offen:
$19.22
24-Stunden-Volumen:
1.46M
Relative Volume:
1.14
Marktkapitalisierung:
$1.02B
Einnahmen:
$110.24M
Nettoeinkommen (Verlust:
$-66.44M
KGV:
-12.56
EPS:
-1.5111
Netto-Cashflow:
$-61.12M
1W Leistung:
-14.47%
1M Leistung:
-4.86%
6M Leistung:
+89.42%
1J Leistung:
-4.48%
1-Tages-Spanne:
$18.45
$19.52
1-Wochen-Bereich:
$18.45
$22.62
52-Wochen-Spanne:
$8.80
$32.71
Beta Bionics Inc Stock (BBNX) Company Profile
Firmenname
Beta Bionics Inc
Sektor
Branche
Telefon
949-427-7785
Adresse
11 HUGHES, IRVINE
Compare BBNX vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
18.98 | 1.16B | 110.24M | -66.44M | -61.12M | -1.5111 |
ABT
Abbott Laboratories
|
98.83 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.29 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.39 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.65 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.32 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-09 | Eingeleitet | UBS | Buy |
| 2026-01-27 | Eingeleitet | TD Cowen | Hold |
| 2026-01-09 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-10-21 | Fortgesetzt | Stifel | Buy |
| 2025-10-01 | Hochstufung | Goldman | Neutral → Buy |
| 2025-06-16 | Eingeleitet | Truist | Buy |
| 2025-06-12 | Eingeleitet | Lake Street | Buy |
| 2025-05-30 | Eingeleitet | Goldman | Neutral |
| 2025-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2025-02-24 | Eingeleitet | BofA Securities | Buy |
| 2025-02-24 | Eingeleitet | Lake Street | Buy |
| 2025-02-24 | Eingeleitet | Leerink Partners | Outperform |
| 2025-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-24 | Eingeleitet | Stifel | Buy |
| 2025-02-20 | Eingeleitet | Ladenburg Thalmann | Neutral |
| 2025-02-20 | Eingeleitet | Robert W. Baird | Neutral |
Alle ansehen
Beta Bionics Inc Aktie (BBNX) Neueste Nachrichten
Faruqi & Faruqi, LLP Urges Beta Bionics (BBNX) Investors to Seek Counsel Before November 3, 2026 Lead Plaintiff Deadline in the Securities Class Action - TMX Newsfile
November 3, 2026 Deadline: Join Class Action Lawsuit Against Beta Bionics, Inc. (BBNX) – Contact Levi & Korsinsky - ACCESS Newswire
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionBBNX - newsfilecorp.com
Investors Urged to Contact Levi & Korsinsky For Information Before November 3, 2026Beta Bionics, Inc. (BBNX) - ACCESS Newswire
Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - Morningstar
Kaplan Fox & Kilsheimer LLP Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before November 3, 2026 - FinancialContent
BBNX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Beta Bionics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Investors in Beta Bionics, Inc. (BBNX): Protect Your RightsContact Levi & Korsinsky Before November 3, 2026 - ACCESS Newswire
Levi & Korsinsky Urges Beta Bionics, Inc. (BBNX) Shareholders to Act Before Lead Plaintiff Deadline November 3, 2026 - accessnewswire.com
BBNX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
DEADLINE ALERT for DKS and BBNX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - GlobeNewswire Inc.
Beta Bionics (BBNX) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before November 3, 2026 Lead Plaintiff Deadline - PR Newswire
BBNX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Beta Bionics (NASDAQ: BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026 - ACCESS Newswire
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files - GlobeNewswire
Lost Money on Beta Bionics, Inc. (BBNX)? Contact Levi & Korsinsky to Join Class Action Before November 3, 2026 - ACCESS Newswire
Beta Bionics, Inc. (BBNX) Receives a Buy from Truist Financial - The Globe and Mail
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Beta Bionics, Inc. (BBNX) Investors of November 3, 2026 Deadline - ACCESS Newswire
Lost Money on Beta Bionics, Inc. (BBNX)? Contact Levi & Korsinsky Before November 3, 2026 to Join Class Action - ACCESS Newswire
November 3, 2026 Deadline: Join Class Action Lawsuit Against Beta Bionics, Inc. (BBNX)Contact Levi & Korsinsky - ACCESS Newswire
BBNX Stockholders Have Rights – If You Lost Money Investing - GlobeNewswire
BBNX Investors: Beta Bionics, Inc. Shares Declined By - GlobeNewswire
ALARUM DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Alarum Technologies Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Beta Bionics, - GlobeNewswire
Securities Fraud Class Action Filed Against Beta Bionics, Inc. (BBNX)Levi & Korsinsky Reminds Investors of November 3, 2026 - ACCESS Newswire
Securities Lawsuit Alert: Beta Bionics, Inc. (BBNX)Contact Levi & Korsinsky Before November 3, 2026 - ACCESS Newswire
BBNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Beta Bionics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Beta Bionics, Inc. (BBNX) LawsuitInvestors Urged to Contact Levi & Korsinsky Before November 3, 2026 - ACCESS Newswire
Beta Bionics Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
Kaplan Fox Class Action Reminder: Beta Bionics, Inc. (NASDAQ: BBNX) Lead Plaintiff Deadline is November 3, 2026 - The National Law Review
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Truist Raises Price Target on Beta Bionics to $28 From $23, Keeps Buy Rating - Yahoo Finance
Levi & Korsinsky Notifies Beta Bionics, Inc. (BBNX) InvestorsLead Plaintiff Deadline on November 3, 2026 - ACCESS Newswire
Beta Bionics, Inc. (BBNX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Class Action Lawsuit Filed: Beta Bionics, Inc. (BBNX) – Join by November 3, 2026 – Contact Levi & Korsinsky - ACCESS Newswire
Investors in Beta Bionics, Inc. (BBNX): Protect Your Rights – Contact Levi & Korsinsky Before November 3, 2026 - ACCESS Newswire
Beta Bionics director Christy Jones sells $147,890 in shares By Investing.com - Investing.com South Africa
Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities - natlawreview.com
BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit - morning-times.com
Contact Levi & Korsinsky by November 3, 2026 to Join Class Action Against Beta Bionics, Inc. (BBNX) - ACCESS Newswire
Form 4 Beta Bionics Inc For: 23 September By Investing.com - Investing.com India
Beta Bionics director Christy Jones sells $147,890 in shares - Investing.com India
BBNX ALERT: Securities Fraud Class Action Launched Against Beta Bionics, Inc.November 3, 2026 Deadline - ACCESS Newswire
Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit Against Beta Bionics, Inc. (NASDAQ: BBNX) is November 3, 2026 - The Globe and Mail
Shareholders of Beta Bionics, Inc. (BBNX): Protect Your Rights Before November 3, 2026Contact Levi & Korsinsky - ACCESS Newswire
BBNX INVESTOR DEADLINE: Beta Bionics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - PR Newswire
After selling shares under a trading plan, director Christy Jones holds 19,564 Beta Bionics (BBNX) shares. - Stock Titan
Beta Bionics Price Target Announced at $28.00/Share by Wells Fargo - Moomoo
BBNX Investor Alert: Johnson Fistel Encourages Beta Bionics, Inc. Investors to Contact the Firm Ahead of November 3, 2026 Lead Plaintiff Deadline - PR Newswire
BBNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Beta Bionics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
BBNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Did You Lose Money on Beta Bionics, Inc. (BBNX)? Levi & Korsinsky Urges Investors to Act Before November 3, 2026 - ACCESS Newswire
Finanzdaten der Beta Bionics Inc-Aktie (BBNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):